Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis: Interim analysis of a TBNET study

J. Dominguez, I. Latorre, M. Tsolia, V. Amanatidou, N. Diez, I. Mialdea, N. Altet, M. Serra, J. Diaz, A. Lacoma, M. De Souza, J. Ruiz-Manzano, E. Giner, C. Prat, A. Escribano, V. Ausina (Badalona, Barcelona, Spain; Athens, Greece)

Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Dominguez, I. Latorre, M. Tsolia, V. Amanatidou, N. Diez, I. Mialdea, N. Altet, M. Serra, J. Diaz, A. Lacoma, M. De Souza, J. Ruiz-Manzano, E. Giner, C. Prat, A. Escribano, V. Ausina (Badalona, Barcelona, Spain; Athens, Greece). Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis: Interim analysis of a TBNET study. Eur Respir J 2012; 40: Suppl. 56, 1873

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010



A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
Source: Eur Respir J 2004; 23: 741-746
Year: 2004



Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010

Genotypes of mycobacterium tuberculosis isolates from autopsy material of HIV-positive tuberculosis patients in Russia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016


Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015



Pulmonary disease caused by non-tuberculous mycobacteria. Descriptive study and comparison with mycobacterium tuberculosis
Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Year: 2011

Clinical resuts of therapy for non-tuberculous myocardium avium complex -Multicentric retrospective study of 581 patients in Japan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Retrospective observation of mycobacterium avium complex lung disease followed without treatment
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007


Clinical importance of pulmonary nontuberculous mycobacteria isolated among HIV-positive individuals in Ghana
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014